Real-world evidence on infection risks from multiple sclerosis treatments remains limited, with inconsistent findings ...

“SWIFT-seq is a powerful option as it can measure the number of CTCs, characterize the genomic alterations of the tumor, ...

Panelists discuss the anticipated 2026 updates to the American Academy of Dermatology guidelines for hidradenitis suppurativa ...

Rising metabolic score for insulin resistance (METS-IR) levels strongly correlate with major cardiovascular events (MACE) and ...

In advanced non–small cell lung cancer (NSCLC), discontinuing immunotherapy after 2 years can maintain durable responses ...

Panelists discuss the challenges of biologic access in hidradenitis suppurativa due to utilization management policies like ...

Patients with chronic lymphocytic leukemia (CLL) had significantly lower monocyte-to-lymphocyte ratio values compared with ...

The humanized IgG4 monoclonal antibody was first approved for myasthenia gravis in the US in 2023, with approvals in Japan ...

Making treatment for non–small cell lung cancer (NSCLC) accessible to a wide range of the population can help to improve ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

A qualitative study found strong support for primary care provider–nephrologist comanagement of chronic kidney disease (CKD), ...

US adults who were displaced and never returned home due to a natural disaster had the highest odds of developing depression or anxiety.